LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

LLY

877.96

-2.32%↓

JNJ

240.27

+0.43%↑

ABBV

209.68

-0.75%↓

NVS

148.25

-0.86%↓

MRK

119.68

+0.62%↑

Inicio・Lista de Acciones・Pliant Therapeutics Inc

Pliant Therapeutics Inc

Cerrado

1.17 -5.65

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

1.16

Máximo

1.17

Métricas clave
By Trading Economics
Ingresos	2.7M -24M
BPA	-0.354
Empleados	49
EBITDA	-5.3M -28M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+128.21% upside

Dividendos
By Dow Jones
Próximas Ganancias	7 may 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-1.2M 80M
Apertura anterior	6.82
Cierre anterior	1.17

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

1.43 / 1.6 Soporte y Resistencia

Pliant Therapeutics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

27 mar 2026, 17:33 UTC

Noticias de Eventos Importantes

ECB Should Not Rush Its Response to Iran Conflict, Says Schnabel -- Update

27 mar 2026, 17:00 UTC

Noticias de Eventos Importantes

ECB Shouldn't Rush Its Response to Iran Conflict, Schnabel Says

27 mar 2026, 16:03 UTC

Noticias de Eventos Importantes

Fertilizer Maker Yara Warns Farmers Are Being Squeezed by Price Surge Amid War -- Commodities Roundup

29 mar 2026, 23:47 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Gold Falls Amid Rising Inflation Fears -- Market Talk

29 mar 2026, 23:46 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Nikkei May Fall on Fears About Shortage of Petrochemical Products -- Market Talk

29 mar 2026, 23:35 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Oil Rises on Supply-Disruption Concerns Spurred by Widening Mideast Conflict -- Market Talk

29 mar 2026, 23:23 UTC

Charlas de Mercado

Australia's National Cabinet to Avoid Covid-Style Measures -- Market Talk

29 mar 2026, 22:34 UTC

Charlas de Mercado

Macroeconomic Tailwind for Warehouse Dissipates -- Market Talk

29 mar 2026, 22:09 UTC

Charlas de Mercado

Amplitude's Next Well "Effectively a Must-Win" for Growth Thesis -- Market Talk

29 mar 2026, 21:06 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Australia's Economy Could Already Be Contracting Amid Oil Shock -- Market Talk

29 mar 2026, 21:03 UTC

Charlas de Mercado

Australia's Government Wants to Avoid Heavy Handed Oil Shock Response -- Market Talk

29 mar 2026, 21:01 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Australian National Cabinet Meeting to Focus on Oil Supply -- Market Talk

29 mar 2026, 09:30 UTC

Adquisiciones, fusiones, absorciones

Food Mega-Mergers Hardly Ever Work. Could McCormick-Unilever Be Different? -- Heard on the Street -- WSJ

28 mar 2026, 08:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

27 mar 2026, 20:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

27 mar 2026, 19:16 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Oil Futures Rise On Uncertainty Ahead of Weekend -- Market Talk

27 mar 2026, 19:07 UTC

Charlas de Mercado

U.S. Natural Gas Gains As April Contract Expires -- Market Talk

27 mar 2026, 19:04 UTC

Charlas de Mercado

Gold Rises But Can't Finish the Week Positive -- Market Talk

27 mar 2026, 19:03 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Global Forex and Fixed Income Roundup: Market Talk

27 mar 2026, 19:02 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Among Central Banks, Canada Has Room to Handle Oil Inflation -- Market Talk

27 mar 2026, 18:12 UTC

Charlas de Mercado

Foreign Fuels and Feedstocks to Get RINs Until 2028 -- Market Talk

27 mar 2026, 17:36 UTC

Noticias de Eventos Importantes

The Iran War and Oil Prices Bring Risk of Deeper Market Lows. There Are Echoes of 2008. -- Barrons.com

27 mar 2026, 17:34 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Delivery Hero Shares Bounce as Stake-Sale Report Whets Investor Appetites -- Market Talk

27 mar 2026, 17:29 UTC

Charlas de Mercado

U.S. Oil Rig Count Falls By 5 to 409 -- Market Talk

27 mar 2026, 16:38 UTC

Charlas de Mercado

Carnival's Outlook Assumes Oil Prices Will Come Down -- Market Talk

27 mar 2026, 16:32 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Chinese Exposure to Higher Energy Costs Seen as Limited -- Market Talk

27 mar 2026, 16:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

27 mar 2026, 15:43 UTC

Charlas de Mercado

Noticias de Eventos Importantes

Hormuz Closure Sends Tanker Rates to Record Highs -- Market Talk

27 mar 2026, 15:25 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

27 mar 2026, 15:25 UTC

Charlas de Mercado

Swiss Franc Dented by Rising European Yields, SNB Intervention Threats -- Market Talk

Comparación entre iguales

Cambio de precio

Pliant Therapeutics Inc previsión

Precio Objetivo

By TipRanks

128.21% repunte

Estimación a 12 Meses

Media 2.67 USD 128.21%

Máximo 3 USD

Mínimo 2 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Pliant Therapeutics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

Comprar

Mantener

Vender

De acuerdo con 5 analistas que ofrecen calificaciones bursátiles a para Pliant Therapeutics Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

1.43 / 1.6Soporte y Resistencia

Recent bearish events outweigh bullish events.

There is one bearish event.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Pliant Therapeutics Inc

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company's lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.